MARKET

DARE

DARE

Dare Bioscience Inc
NASDAQ
0.8428
-0.0082
-0.96%
After Hours: 0.8499 +0.0071 +0.84% 19:53 10/02 EDT
OPEN
0.8690
PREV CLOSE
0.8510
HIGH
0.8775
LOW
0.8224
VOLUME
148.40K
TURNOVER
--
52 WEEK HIGH
3.780
52 WEEK LOW
0.6900
MARKET CAP
16.58M
P/E (TTM)
-1.0708
1D
5D
1M
3M
1Y
5Y
1D
Daré Bioscience Faces Nasdaq Minimum Bid Price Noncompliance
TipRanks · 1d ago
Daré Bioscience Says It Received Nasdaq Minimum Bid Price Deficiency Notice, Has Until March 29, 2027 To Regain Compliance
Benzinga · 1d ago
Daré Bioscience Releases Updated Investor Corporate Presentation
TipRanks · 2d ago
Dare Bioscience announces issuance of patent for DARE-HPV program
TipRanks · 5d ago
Daré Bioscience Receives U.S. Patent For Its Pharmaceutical Compositions Formulated For Topical Application Comprising Lopinavir, Ritonavir To Treat Cervical Pathologies
Benzinga · 5d ago
Weekly Report: what happened at DARE last week (0921-0925)?
Weekly Report · 5d ago
Dare Bioscience Announces New U.S. Patent Strengthening DARE-HPV Program as a Potential First FDA-Approved Pharmacologic Treatment for HPV Infection
Barchart · 5d ago
Analysts’ Top Healthcare Picks: IN8bio (INAB), Daré Bioscience (DARE)
TipRanks · 09/22 10:00
More
About DARE
Dare Bioscience, Inc. is a biopharmaceutical company. The Company's programs target unmet needs in women's health, primarily in the areas of contraception, sexual health, pelvic pain, fertility, infectious disease, vaginal health and menopause. Its product includes XACIATO (clindamycin phosphate) vaginal gel 2%. XACIATO is a single-dose prescription medication for the treatment of bacterial vaginosis in females 12 years of age and older. Its other product candidates include Ovaprene, Sildenafil Cream, and DARE-HRT1. Ovaprene is an investigational, hormone-free, monthly intravaginal contraceptive. Sildenafil Cream is a novel cream formulation of sildenafil for the treatment of female sexual arousal disorder; and DARE-HRT1 is an intravaginal ring designed to deliver a combination of menopausal hormone therapy, bio-identical 17b-estradiol and progesterone together, continuously over a 28-day period for the treatment of moderate to severe vasomotor symptoms, also known as hot flashes.

Webull offers Dare Bioscience Inc stock information, including NASDAQ: DARE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DARE stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading DARE stock methods without spending real money on the virtual paper trading platform.